Helix Insight

Documentation / Computational Predictors / DANN

DANN

Displayed for clinical reference. Does not contribute to ACMG classification.

What DANN Is

DANN (Deleterious Annotation of genetic variants using Neural Networks) is a deep neural network trained to distinguish pathogenic from benign variants using a large set of genomic annotations. It uses the same training features as the CADD scoring system but applies a deep learning architecture instead of a linear model, which allows it to capture more complex relationships between features.

Score Interpretation

DANN scores range from 0 to 1, with higher scores indicating a greater likelihood of pathogenicity.

Score RangeInterpretation
>= 0.95Predicted damaging with high confidence
0.5 -- 0.95Ambiguous range -- insufficient confidence for a clear prediction
< 0.5Predicted benign

Strengths and Limitations

DANN's primary strength is breadth: it can score any single nucleotide variant in the genome, not just missense variants in coding regions. This makes it useful as a reference for intronic, synonymous, and UTR variants where protein-specific tools like SIFT or AlphaMissense are not applicable.

The main limitation is its wide ambiguous range (0.5 to 0.95), which means many variants receive scores that are neither clearly damaging nor clearly benign. The binary threshold approach may also miss nuanced pathogenicity signals.

Role in Helix Insight

DANN scores are displayed in the variant detail view as additional clinical context. They do not contribute to PP3 or BP4 ACMG criteria. The formal classification uses BayesDel_noAF with ClinGen SVI calibrated thresholds. See Consensus Calculation for details.

Reference: Quang D, Chen Y, Xie X. Bioinformatics. 2015;31(5):761-763. PMID: 25338716